Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis

results of the open-label, pragmatic, cluster-randomised TICOSPA trial

Ann Rheum Dis. 2021 Nov; 80(11):1436-1444.

Objectives:

To compare the benefits of a tight-control/treat-to-target strategy (TC/T2T) in axial spondyloarthritis (axSpA) with those of usual care (UC).

https://pubmed.ncbi.nlm.nih.gov/33958325/

Vous souhaitez échanger
avec nos équipes

D’autres articles qui pourraient
vous intéresser

Impact of disease activity for patients with axial spondyloarthritis

Rhumatologie

Impact of disease activity for patients with axial spondyloarthritis

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

Rhumatologie

Impact of terminating reimbursement of symptomatic slow-acting drugs in osteoarthritis in France

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL

Rhumatologie

THU0370 CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL